Elix Cycle Balance and Elix Daily Harmony for fibroid-related symptoms
Official title: An Open-Label, Single-Group Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
Run by Zenchi, Inc. · NCT07078682 · Data updated 2026-11-12
This 24-week virtual study will test whether taking the herbal supplements Elix Cycle Balance and Elix Daily Harmony daily can reduce menstrual pain and other fibroid-related symptoms in women aged 20–45 with uterine fibroids.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 45 Years |
| Sex | Women only |
| Enrollment | 42 (estimated) |
| Sponsor | Zenchi, Inc. Industry-sponsored |
| Locations | 1 site (Las Vegas, Nevada) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | January 2026 |
| Study ends | January 2026 |
| Registry record updated | September 12, 2025 |
| Trial ID | NCT07078682 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 20–45 with a prior diagnosis of uterine fibroids, a BMI of 18.5–24.9, and at least six months of moderate-to-severe menstrual cramps who can take daily supplements and complete online questionnaires are ideal candidates.
✕Probably not a fit
People outside the specified age or BMI range, those with uncontrolled chronic disease, or those who cannot keep medications and supplements stable during the study are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a 24-week, single-arm, open-label virtual study enrolling 42 participants with a prior diagnosis of uterine fibroids. Participants will self-administer the investigational herbal supplements daily and complete validated questionnaires at scheduled timepoints to measure symptom severity and quality of life. The protocol requires consistent use of any existing hormonal birth control or supplements and prohibits introducing new medications or supplements during the study. Outcomes are based on patient-reported measures collected remotely and the study does not include a placebo or blinded comparator.
Why it matters
Potential benefit: If successful, the supplements could offer a non-prescription option to reduce menstrual pain and improve quality of life for women with fibroids.
How similar studies have gone: Some small or preliminary trials of herbal and dietary approaches have reported symptom improvements, but high-quality evidence for these specific products is limited and the approach remains largely unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be female. * Be aged 20-45. * BMI 18.5 - 24.9 kg/m2 * Self-reported prior diagnosis of uterine fibroids. * Anyone who is generally healthy - does not live with any uncontrolled chronic disease. * Self-reported moderate to severe discomfort during menstruation, related to pelvic cramps, bloating, mood swings, or fatigue. * Self-reported menstrual cramps during their cycle, for the past six months minimum. * If taking hormonal birth control, has been doing so consistently for at least three months, and experiences a menstrual cycle with a period. * If taking other oral over-the-counter supplements or herbal remedies, has been consistently taking these for at least three months prior to starting the study, and is willing to maintain this routine for the study duration. * Willing to refrain from introducing any products or any new forms of medication or supplements for the study duration. * Willing to refrain from any other dietary supplements or herbal remedies targeting the menstrual cycle during the study period. * Willing to refrain from any new vaccines during the 6 month period. * Follows a stable, consistent exercise regimen and are willing, for the duration of the study, to not decrease or increase the amount of exercise in their regimen. * Agrees to refrain from any lifestyle changes that may affect their menstrual cycle for the duration of the study (for example, getting on or off hormonal birth control, reducing the amount of exercise). * If using any other interventions, such as massage, chiropractic medicine, or acupuncture, agrees not to increase or decrease the number of these other interventions during the study period. * Resides in the United States. Exclusion Criteria: * Does not experience a regular menstrual cycle (21-35 days). * Does not experience menstrual cramping. * Follows an extreme diet intervention such as dry fasts, water fasts, or ketogenic diets. * Anyone who has experienced significant weight loss in the past three months prior to study participation. * Unwilling to stop the use of any medication or herbal remedies/supplements that can affect the menstrual cycle. * Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders. * Anyone with known severe allergic reactions. * Anyone with any allergies or sensitivities to any of the study product ingredients. * Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period). * Anyone unwilling to follow the study protocol. * Has stopped, started, or changed hormonal birth control in the past three months. * Previous users of Elix Cycle Balance. * Anyone who is currently a smoker or has been a smoker in the past 3 months. * Anyone who has been diagnosed with the following conditions: PCOS, Endometriosis, PMDD, Adenomyosis, Hashimoto's thyroiditis, Grave's disease (and any other thyroid disorders), hyperprolactinemia, Cushing's disease, congenital adrenal hyperplasia, anorexia, bulimia, orthorexia, binge eating, any other eating disorder. * History of endocrine disorders such as thyroid disorder, Type 1 or 2 diabetes, or other. * History of hypertension, hyperlipidemia, or previous venous embolism. * Overweight/obesity (BMI \> 25 kg/m2). * Women with other causes of chronic pelvic pain, including infectious disease, gastrointestinal, psychological disorders, fibromyalgia, and chronic fatigue syndrome. * Hysterectomy, myomectomy, or bilateral salpingo-oophorectomy or other gynecological medical or surgical treatment in the last 6 months. * History of an abnormal pap smear. * History of neoplasia of gynecological origin and/or existence of uterine malformations. * Chronic urinary tract infections or diagnosed functional gastrointestinal conditions like IBS, IBD, Crohn's disease, or ulcerative colitis. * Currently partaking in another research study or will be partaking in any other research study for the next 24 weeks, or at any point during this study's duration. * Consume more than 5 alcoholic drinks per week * Had a vaccine in the last 3 months
Where it's running
-
Citruslabs
Las Vegas, Nevada, United States Recruiting
Study contacts
- Study coordinator: Patrick Renner, MSc
- Email: hello@citruslabs.com
- Phone: 4242450284
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predictors of Success and Failure of v-NOTES Hysterectomy for Large Uteri
This study looks at which factors predict whether a v-NOTES hysterectomy for large uteri will be completed without needing to switch to another surgical approach.
-
Virtual reality for reducing pain and anxiety in women with menstrual cramps
In women with primary dysmenorrhea, this study tests whether a relaxing virtual reality experience can lower pain and anxiety during a 3-day period.
-
Self-acupressure to reduce period pain and premenstrual symptoms
This trial will test whether a self-acupressure routine can reduce period pain and premenstrual symptoms in university students aged 18–30 with primary dysmenorrhea.
-
High-intensity interval training to reduce menstrual pain and improve menstrual health in women with primary dysmenorrhea
This 12-week program will try supervised online high-intensity interval training plus a menstrual health workshop to see if it reduces menstrual pain and improves quality of life for women aged 18–40 with primary dysmenorrhea.
-
KLH-2109 for heavy menstrual bleeding from uterine fibroids
We are testing whether KLH-2109 can reduce heavy menstrual bleeding in people with uterine fibroids.
-
How pelvic organ pain affects muscles and the automatic nervous system in women with painful periods
We will test whether women with painful periods show bigger muscle and automatic nervous system (heart-rate variability) responses to a brief pelvic pain stimulus than women without painful periods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.